Stock Analiz

Moderna, Inc. (MRNA) stock forecast and price target

Price $223.37 · data as of November 13, 2026

12-month price target

Average target$158.47
Upside / downside−29.1%
Analysts19
ConsensusHold
Low $45.00Average $158.47High $305.00

Gold marker: average target · white marker: today’s price ($223.37)

Analyst ratings

Strong buy 1Buy 3Hold 16Sell 2Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-7.36−1.8%$2.4B
Next fiscal year
ends December 31, 2027
$-4.43+43.6%$2.7B
Next quarter
ends December 31, 2026
$-2.14−6.3%$598M
Quarter after
ends March 31, 2027
$-1.73+47.6%$281M

Consensus of the analysts covering Moderna, updated daily. In the last 30 days 6 estimates were raised and 2 lowered.

Frequently asked questions

What is the Moderna stock price target?

The average 12-month target from 19 analysts is $158.47, 29.1% below the current price of $223.37 Targets range from $45.00 to $305.00.

Is Moderna a buy according to analysts?

The consensus rating is “Hold” (1 strong buy, 3 buy, 16 hold, 2 sell, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Moderna expected to earn?

Analysts expect EPS of $-7.36 for the fiscal year ending December 31, 2026 and $-4.43 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.